These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38940326)

  • 1. Interplay between Wnt signaling molecules and exosomal miRNAs in breast cancer (Review).
    Li H; Li X; Du W
    Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38940326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Features and Therapeutic Implications Related to the MiRNAs and Wnt Signaling Regulatory in Breast Cancer.
    Talebi M; Farkhondeh T; Harifi-Mood MS; Talebi M; Samarghandian S
    Curr Mol Pharmacol; 2023; 16(5):530-541. PubMed ID: 36263474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
    Wang L; He M; Fu L; Jin Y
    Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-135 regulated breast cancer proliferation and epithelial-mesenchymal transition acts by the Wnt/β-catenin signaling pathway.
    Jiang D; Zhou B; Xiong Y; Cai H
    Int J Mol Med; 2019 Apr; 43(4):1623-1634. PubMed ID: 30720046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of exosomal miR-455-5p and miR-1255a as therapeutic targets for breast cancer.
    Xin Y; Wang X; Meng K; Ni C; Lv Z; Guan D
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31763681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of exosomal miRNAs in breast cancer drug resistance.
    Najminejad H; Kalantar SM; Abdollahpour-Alitappeh M; Karimi MH; Seifalian AM; Gholipourmalekabadi M; Sheikhha MH
    IUBMB Life; 2019 Nov; 71(11):1672-1684. PubMed ID: 31322822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
    Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal microRNA: a novel biomarker for breast cancer.
    He Y; Deng F; Yang S; Wang D; Chen X; Zhong S; Zhao J; Tang J
    Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
    Sun WM; Tao W; Li JC; Zhu DM; Miao Y
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of regulatory miRNAs of the Wnt/ β-catenin signaling pathway in tumorigenesis of breast cancer.
    Rahmani F; Tadayyon Tabrizi A; Hashemian P; Alijannejad S; Rahdar HA; Ferns GA; Hassanian SM; Shahidsales S; Avan A
    Gene; 2020 Sep; 754():144892. PubMed ID: 32534060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN.
    Shan G; Zhou X; Gu J; Zhou D; Cheng W; Wu H; Wang Y; Tang T; Wang X
    Cell Oncol (Dordr); 2021 Feb; 44(1):45-59. PubMed ID: 33423167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-κB signaling pathway.
    Wang B; Mao JH; Wang BY; Wang LX; Wen HY; Xu LJ; Fu JX; Yang H
    Cancer Lett; 2020 Oct; 489():87-99. PubMed ID: 32531321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway.
    Liang Z; Liu L; Gao R; Che C; Yang G
    Cell Mol Biol Lett; 2022 Oct; 27(1):88. PubMed ID: 36210461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
    Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring signaling pathway crosstalk in glioma by mapping miRNA and WNT pathways: A review.
    Isa AI
    Int J Biol Macromol; 2024 Feb; 257(Pt 2):128722. PubMed ID: 38092099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition.
    Zhang X; Bai J; Yin H; Long L; Zheng Z; Wang Q; Chen F; Yu X; Zhou Y
    Mol Oncol; 2020 Oct; 14(10):2589-2608. PubMed ID: 32679610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients.
    Schwarzenbach H
    Oncol Res Treat; 2017; 40(7-8):423-429. PubMed ID: 28683441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal microRNAs in hepatocellular carcinoma, expanding research field.
    Zheng BH; Ni XJ; Liu HB
    World J Gastroenterol; 2024 May; 30(20):2618-2620. PubMed ID: 38855155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.